All In Biotech

Drug Trial Radar · NCT00215592

Open Label, Zonegran (Zonisamide) In Partial Onset Seizures

An Open Label Study Of Zonegran (Zonisamide) In Patients With Partial Onset Seizures

Last checked: Nov 20, 2026Latest source record: Jan 8, 2016 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

1,000

Actual

Start

Oct 2005

Primary completion

Jul 2007

Sponsor

Lead sponsor
Eisai LimitedEisai
Sponsor type
Industry
First posted
Sep 22, 2005

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Non randomized
Model
Single group
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

To determine the efficacy and safety of adjunctive open label Zonegran treatment in patients with refractory partial seizures.

Conditions

  • Epilepsy

Interventions

  • ZonegranDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Seizure frequency, compared to baseline.

Locations

33 sites in 7 countries. Site status is shown where the registry gives one.

  • Universitatsklinikum fur Neurologie

    Innsbruck, Austria

  • Danish Epilepsy Center

    Dianalund, Denmark

  • The Epilepsy Clinic

    Glostrup Municipality, Denmark

  • Centre Hospitalier d'Annecy

    Annecy, France

  • CH Germon et Gauthier

    Béthune, France

  • Hopital Pellegrin Tripode

    Bordeaux, France

  • Hopital Gabriel Montpied

    Clermont-Ferrand, France

  • Hopital General

    Dijon, France

  • Hopital Victor Jousselin

    Dreux, France

  • Cabinet de neurologie

    Gap, France

  • Hopital de la Timone Adultes

    Marseille, France

  • Groupe hospitalier Pitie Salpetriere

    Paris, France

  • Hopital de Font Pre

    Toulon, France

  • CHU Bretonneau

    Tours, France

  • Universitatsklinikum Campus Virchow-Klinikum Wedding

    Berlin, Germany

  • Epilepsieklinik Tabor

    Bernau B. Berlin, Germany

  • Universitat Freiburg

    Freiburg im Breisgau, Germany

  • Epilepsiezentrum Kork

    Kehl-Kork, Germany

  • Arzneimittelforschung Leipzig GmbH

    Leipzig, Germany

  • Klinik die Weissenau

    Revensburg, Germany

  • Ospedale Riuniti di Bergamo

    Bergamo, Italy

  • Azienda Ospedaliero- Universitaria Policlinico di Catania

    Catania, Italy

  • Istituto Nazionale Neurologico Carlo Besta di Milano

    Milan, Italy

  • Azienda Ospedaliera San Paolo

    Milan, Italy

  • Universita di Parma

    Parma, Italy

  • Azienda Ospedaliera Bianchi-Melancrino-Morelli

    Reggio Calabria, Italy

  • Universita degli studi La Sapienza

    Roma, Italy

  • Universita degli Studi La Sapienza

    Roma, Italy

  • Nevrologisk avdelning, 10 etasje

    Lillehammer, Norway

  • Sandvika Neurologpraksis

    Sandvika, Norway

  • Avd. for nevrologi og klinisk nevrofysiologi

    Trondheim, Norway

  • University Hospital of Wales

    Cardiff, United Kingdom

  • University Hospital of North Staffordshire Royal Infirmary

    Stoke-on-Trent, United Kingdom

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.